Multiple Sclerosis Awareness Month: Understanding Infusion Therapy and the Importance of Access to Care
March is Multiple Sclerosis Awareness Month, a time to raise awareness of a complex neurological condition that affects nearly one million people in the United States.
For people living with multiple sclerosis, treatment is not just about managing symptoms in the moment. It is about preserving function, maintaining independence and supporting long-term stability whenever possible. As treatment options for MS have continued to evolve, infusion and clinically administered therapies have become an important part of care for many patients.
Medications such as OCREVUS®, TYSABRI®, BRIUMVI® and OCREVUS ZUNOVO® have expanded treatment options for patients and providers, but access to care remains a critical part of the equation. Choosing the right therapy matters and so does choosing the right place to receive it.
What is Multiple Sclerosis?
Multiple sclerosis, often referred to as MS, is a chronic disease that affects the central nervous system, including the brain and spinal cord. It occurs when the immune system attacks the protective covering around nerve fibers, disrupting communication between the brain and the rest of the body.
Symptoms can vary widely and may include fatigue, numbness, weakness, balance issues, vision changes, pain and difficulty with mobility. Because MS can be unpredictable, treatment plans are designed to reduce disease activity, manage symptoms and help slow progression over time.
Why Infusion Therapy Is Part of MS Treatment
Not every person with MS will require infusion therapy, but for many patients, it plays an important role in long-term disease management. Some therapies are delivered through IV infusion, while others are administered in a clinical setting under medical supervision.
Common clinically administered MS therapies include:
- OCREVUS® (ocrelizumab)
- TYSABRI® (natalizumab)
- BRIUMVI® (ublituximab-xiiy)
- OCREVUS ZUNOVO® (ocrelizumab and hyaluronidase-ocsq)
These treatments are selected based on a patient’s diagnosis, disease course, treatment history and clinical needs. The goal is to reduce relapses, slow progression and support better long-term outcomes.
Because these medications are administered on a defined schedule, consistency matters. Delays in treatment, appointment challenges or administrative barriers can interrupt care and create unnecessary stress for both patients and providers.
Access to Care Has a Real Impact on Treatment
When people think about MS treatment, the focus is often on the medication itself. That is an important part of the story, but it is not the whole story. Access to care can have a major impact on the treatment experience.
Patients receiving infusion or supervised MS therapies may encounter:
- Prior authorization requirements
- Insurance verification delays
- Limited appointment availability
- Long wait times in hospital-based settings
- Gaps in communication between care teams
For patients, these challenges can make treatment feel harder to begin and more difficult to maintain. For providers, they can create added complexity and make it more difficult to keep care plans moving forward as intended.
That is where the site of care becomes especially important.
Why the Infusion Setting Matters
Infusion therapy for MS may be delivered in a hospital outpatient department, specialty clinic or dedicated ambulatory infusion center. Each setting offers a different patient experience, operational process, and level of flexibility.
Outpatient infusion centers, like Immersiv Health, can often provide meaningful advantages, including:
- More flexible and timely scheduling
- A calmer and more comfortable setting
- Consistent clinical oversight
- Streamlined coordination throughout treatment
For patients managing a chronic condition, these factors can make a meaningful difference in how manageable treatment feels over time.
What Patients and Providers Should Look for in an Infusion Partner
A strong infusion provider should do more than administer medication. The right infusion partner helps reduce barriers, streamline logistics and support a smoother care journey from referral through treatment.
That includes:
- Benefits verification and insurance coordination
- Prior authorization support
- Efficient scheduling to help avoid treatment delays
- Ongoing communication with referring providers
- A consistent, supportive clinical environment
- Assistance identifying available co-pay support or grant options when appropriate
These may sound like operational details, but they directly affect the patient experience. When care is easier to access and better coordinated, patients are more likely to begin treatment on time and stay on track with their care plan.
Common Questions About MS Infusion Therapy
What is the difference between infusion and injection therapies for MS?
Infusion therapies are administered through an IV over a set period of time in a clinical setting. Some newer therapies, like OCREVUS ZUNOVO®, are delivered as injections but still require clinical supervision.
How often are MS infusions given?
That depends on the medication. Some therapies are administered every few weeks, while others may be given every six months. The schedule varies based on the drug and the patient’s treatment plan.
Why do these treatments require a clinical setting?
These medications often require monitoring during and after administration to support safety, manage potential reactions, and ensure the treatment is delivered appropriately.
Why This Matters During Multiple Sclerosis Awareness Month
Multiple Sclerosis Awareness Month is not only about understanding the condition itself. It is also about recognizing what it takes to support patients throughout the full care journey.
That includes access to treatment, coordination between care teams, support with insurance and financial questions and the ability to receive therapy without unnecessary delays or added barriers.
For patients, that can mean a more stable, predictable and manageable care experience. For providers, it supports better continuity and greater confidence that patients are receiving treatment in a setting that aligns with the plan of care.
Why Immersiv Health Is a Right Choice for Infusion Care
For patients receiving therapies such as OCREVUS®, TYSABRI®, BRIUMVI® and OCREVUS ZUNOVO®, the infusion experience plays an important role in overall care.
Immersiv Health is built to make that experience more accessible, coordinated and efficient for both patients and referring providers. Our team supports the full process, from benefits verification and prior authorizations to scheduling, treatment coordination and ongoing communication. That helps reduce administrative burden for providers while making it easier for patients to start and stay on therapy without unnecessary delays.
We also provide a controlled outpatient setting designed around comfort, consistency and timely access to care. For patients, that means a more supportive experience. For providers, it means having a trusted extension of the care team focused on helping treatment move forward smoothly.
At the end of the day, infusion care should not create more friction than the condition already does. It should make the process easier to navigate, easier to coordinate and easier to stay on track.
That is exactly where Immersiv Health delivers value and is your partner for infusion therapy.
